Zag Bio(TM) Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases GlobeNewswire October 28, 2025 Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body's natural mechanism to induce central tolerance Lead program in Type 1 diabetes is advancing toward the clinic, with […]

Americold Ireland Achieves Exclusive U.S. Meat Export Certification and Five AA-Rated Audits, Reinforcing Global Cold Chain Leadership GlobeNewswire October 28, 2025 ATLANTA, GA., Oct. 28, 2025 (GLOBE NEWSWIRE) — Americold, a global leader in temperature-controlled logistics, real estate, and value-added services, today announced that its Dublin facility has been certified by Ireland's Department of Agriculture,

Castle Biosciences to Participate in Upcoming Investor Conferences GlobeNewswire October 28, 2025 FRIENDSWOOD, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Stephens 27th Annual Investment

Entrada Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire October 28, 2025 BOSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the Company will participate in two upcoming investor conferences. Jefferies Global Healthcare Conference in LondonDipal Doshi, Chief Executive Officer, will deliver a company presentation on Tuesday, November 18, 2025,

Climb Channel Solutions Announces North American Partnership with Halcyon GlobeNewswire October 28, 2025 EATONTOWN, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) announced the launch of their partnership with Halcyon, the leading anti-ransomware solution provider. The partnership

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market GlobeNewswire October 28, 2025 CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide

Abcourt obtains its environmental certificate of authorization for custom milling at the Sleeping Giant Mill GlobeNewswire October 28, 2025 ROUYN-NORANDA, Quebec, Oct. 28, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) is pleased to announce the receipt of its environmental certificate of authorization for custom milling

Stella-Jones to Hold Investor Day GlobeNewswire October 28, 2025 MONTREAL, Oct. 28, 2025 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced it will hold an investor day on Thursday, November 20, 2025 for institutional investors and research analysts in Toronto, Ontario. The event will begin at 9 a.m. Eastern Standard

EVgo to Report Third Quarter 2025 Results on November 10 GlobeNewswire October 28, 2025 LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) — EVgo Inc. (Nasdaq: EVGO), one of the nation's largest providers of public fast charging infrastructure for electric vehicles (EVs), today announced that it will release its third quarter 2025 financial results on Monday,

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch GlobeNewswire October 28, 2025 Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA(TM) FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received final meeting minutes from FDA and is incorporating the feedback